KUKJE PHARMA Co., Ltd.
002720.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$90.35B
Close$
$8823.36
128% upside
Current Fair Value
128% upsideUndervalued by 128% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $90.35 Billion |
|---|---|
| Enterprise Value | $109.35 Billion |
| Dividend Yield | $30.00 (0.70%) |
| Earnings per Share | $279.51 |
| Beta | 0.27 |
| Outstanding Shares | 21,159,832 |
Return
| Return on Equity | 5.03% |
|---|---|
| Return on Assets | 2.70% |
| Return on Invested Capital | 4.28% |
Valuation & Multiples
| P/E Ratio | 17.8 |
|---|---|
| PEG | -47.79 |
| Price to Sales | 0.45 |
| Price to Book Ratio | 0.82 |
| Enterprise Value to Revenue | 0.6 |
| Enterprise Value to EBIT | 21.02 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About KUKJE PHARMA Co., Ltd.
272 employees
CEO: Taehoon Nam KUKJE PHARMA Co. Ltd. engages in the manufacture, sale, and distribution of pharmaceutical, cosmetics, and healthcare products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antibiotics, and a...